Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of dabigatran and enoxaparin in prophylaxis of thromboembolic events after total knee replacement
IRCT2013082513828N2Phase 2Completed
- Sponsor
- ُSoicial Security Insurance Office/ Shariati Hospital
- Start
- Aug 2013
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dabigatran and enoxaparin in venous thromboembolism (VTE) (2 arms), sponsored by ُSoicial Security Insurance Office/ Shariati Hospital. Started Aug 2013; status: completed.
02
Drugs
dabigatranenoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on IRCT2013082513828N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013082513828N2.